- (1) The license shall develop policy regarding the use of special treatment procedures to include the use of seclusion and restraint in accordance with Section R432-101-23.
(2) The licensee shall ensure special treatment policies and procedures address:
- (a) the use of convulsive therapy including electroconvulsive therapy;
- (b) the use of psychosurgery or other surgical procedures for the intervention or alteration of a mental, emotional or behavioral disorder;
- (c) the use of behavior modification with painful stimuli;
- (d) the use of unusual, investigational and experimental drugs;
- (e) the use of drugs associated with abuse potential and those having substantial risk or undesirable side effects;
- (f) an explanation as to whether the hospital will conduct research projects involving inconvenience or risk to the patient; and
- (g) involuntary medication administration for emergent and ongoing treatment.
KEY: health care facilities
Date of Last Change: November 1, 2023
Notice of Continuation: September 1, 2025
Authorizing, and Implemented or Interpreted Law: 26B-2-202